Get ready for an exciting announcement for the melanoma community

Days
Hours
Minutes

A Study to Estimate the Anti-Tumor Activity and Identify Potential Predictors of Response in Patients with Advanced Mucosal or Acral Lentiginous Melanoma Receiving Standard Nivolumab in Combination with Ipilimumab followed by Nivolumab Monotherapy

Melanoma Research Program at Georgetown University

Award Type	Team Awards
Institution	Georgetown University
Donor Support	MRF Breakthrough Consortium Award

TOGETHER WE CAN FUND THE FUTURE!

Donate what you can

YOUR GENEROSITY ADVANCES LIFE-SAVING MELANOMA RESEARCH.

THANK YOU!


 

    
Name:
 

 


 
Email:




	

				

				

		

				
			
                 
 
                        
                            Become an Advocate
                        
                        Name*
                            
                            
                                                    
                                                    First
                                                
                            
                                                    
                                                    Middle
                                                
                            
                                                    
                                                    Last
                                                
                            
                                                    
                                                    Suffix
                                                
                        
Title
Professional Suffix
Organization
Email*
                            
                        
Address*    
                    
                         
                                        
                                        Street Address
                                    
                                        
                                        Address Line 2
                                    
                                    
                                    City
                                 
                                        
                                        State
                                      
                                    
                                    ZIP / Postal Code
                                
                    
                
Phone
I identify as*
I am interested in more information about…
CAPTCHA
                            
          
            
            
            
            
            
            
            
            
            
        
                        
                        
		


				

				            
		
	


    
    
    
    
	
	
    PATIENTS & CAREGIVERS▼Newly Diagnosed
Treatment Center Finder
Find Support▼Patient Forum
Patient & Caregiver Meetings
Connect with Others
Survivorship
Bereavement
Financial Assistance
Clinical Trials
Cutaneous Melanoma▼Diagnosis (Cutaneous)
Treatment (Cutaneous)
Resources (Cutaneous)
Ocular Melanoma
Mucosal Melanoma▼Diagnosis (Mucosal)
Treatment (Mucosal)
Resources (Mucosal)
Pediatric & AYA Melanoma▼Diagnosis (Pediatric)
Treatment (Pediatric)
Resources (Pediatric)
MELANOMA EDUCATION▼Understand Melanoma▼What Melanoma Looks Like
Facts & Stats
Cutaneous Melanoma
Ocular Melanoma
Mucosal Melanoma
Pediatric & AYA Melanoma
Melanoma Prevention
Melanoma Awareness
Skin of Color & Melanoma
Education Institute
Provider Education
Courses
Patient Meetings
RESEARCH & SCIENCE▼Research Grants▼Research Grant RFPs
Funded Research
Supported Institutions
Scientific Initiatives▼VISION Registry
MRF Breakthrough Consortium
CURE Ocular Melanoma
Pediatric & Mucosal Melanoma
Scientific Meetings
Partnerships
Participate in Science▼Participate in Clinical Trials
Advocate for Legislative Issues
Review Grant Applications
Fundraise
Scientific Leadership
ADVOCATE▼Our Impact
Advocacy Priorities▼Federal Funding
Prevention
Access
Education
Take Action
Advocacy News
Advocacy Events
Global Melanoma Coalition
CURE OM▼Diagnosis
Treatment
Resources
VISION Platform
HOW TO HELP▼Planned Giving
Give
Memorial Giving
Endowment
Volunteer
Corporate Sponsorship
Cause Marketing
Merch Store
EVENTS▼Galas
Miles for Melanoma
Host an Event
Patient Symposium
Advocacy
Scientific Meetings
ABOUT US▼Staff
Board of Directors
Scientific Leadership
News & Press▼SPOTlight Newsletter
Eye on OM Newsletter
Advocacy Newsletter
Programs & Initiatives▼CURE Ocular Melanoma
Pediatric & Mucosal Melanoma
Financials & Annual Reports
Careers
Contact

Get ready for an exciting announcement for the melanoma community

A Study to Estimate the Anti-Tumor Activity and Identify Potential Predictors of Response in Patients with Advanced Mucosal or Acral Lentiginous Melanoma Receiving Standard Nivolumab in Combination with Ipilimumab followed by Nivolumab Monotherapy

Melanoma Research Program at Georgetown University

TOGETHER WE CAN
FUND THE FUTURE

Research Grant Opportunities

Stay Updated

Become an Advocate